Subjects: PROTEINURIA; IMMUNOSUPPRESSIVE agents; LUPUS nephritisUNITED States. Food & Drug Administration
Record details
Subjects: RISK assessment; PROTEINURIA; RESEARCH funding
Subjects: THERAPEUTIC use of monoclonal antibodies; DRUG efficacy; RITUXIMAB
Subjects: KIDNEY physiology; DRUG efficacy; PROTEINS
Subjects: RITUXIMAB; NEPHROTIC syndrome; CHILDREN'S hospitals
Subjects: SYSTEMIC lupus erythematosus; B cells; LUPUS nephritis
Subjects: COMPLEMENT (Immunology); BIOPSY; SERODIAGNOSIS
Subjects: PILOT projects; B cells; CLINICAL trials
Subjects: BIOMARKERS; FLOW cytometry; AUTOANTIBODIES
Subjects: THERAPEUTIC use of glucocorticoids; NEPHROTIC syndrome diagnosis; CHRONIC kidney failure